The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community

Yasuyuki Honda; Yejin Mok; Junichi Ishigami; Kellan E. Ashley; Ron C. Hoogeveen; Christie M. Ballantyne; Amy B. Karger; David Couper; Elizabeth Selvin; Kunihiro Matsushita

doi:10.1016/j.jacc.2021.08.066

The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community

Yasuyuki Honda
, Yejin Mok
, Junichi Ishigami
, Kellan E. Ashley
, Ron C. Hoogeveen
, Christie M. Ballantyne
, Amy B. Karger
, David Couper
, Elizabeth Selvin
, Kunihiro Matsushita

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2019-2021
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	78
Issue number	20
DOIs	https://doi.org/10.1016/j.jacc.2021.08.066
State	Published - Nov 16 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2021.08.066

Cite this

@article{65621138be374fbb91f0093798945e33,

title = "The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community",

author = "Yasuyuki Honda and Yejin Mok and Junichi Ishigami and Ashley, \{Kellan E.\} and Hoogeveen, \{Ron C.\} and Ballantyne, \{Christie M.\} and Karger, \{Amy B.\} and David Couper and Elizabeth Selvin and Kunihiro Matsushita",

note = "Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions. Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions.",

year = "2021",

month = nov,

day = "16",

doi = "10.1016/j.jacc.2021.08.066",

language = "English (US)",

volume = "78",

pages = "2019--2021",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "20",

}

TY - JOUR

T1 - The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community

AU - Honda, Yasuyuki

AU - Mok, Yejin

AU - Ishigami, Junichi

AU - Ashley, Kellan E.

AU - Hoogeveen, Ron C.

AU - Ballantyne, Christie M.

AU - Karger, Amy B.

AU - Couper, David

AU - Selvin, Elizabeth

AU - Matsushita, Kunihiro

N1 - Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions. Funding Information: The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I. Cardiac troponin T and serum creatinine were measured as an ancillary study (principal investigator, Dr. Matsushita) supported by Kyowa Kirin. Roche Diagnostics provided reagents to measure the 5th generation cardiac troponin T. Dr Hoogeveen has received institutional research funding and consulting fees from Denka Seiken outside the scope of this work. Dr Ballantyne has been a consultant for Roche and Abbott Diagnostics. Dr Karger has been a consultant for Roche Diagnostics; and has received research funding from Siemens Healthcare Diagnostics. Dr Couper has received institutional research funding from Denka Seiken outside the scope of this work. Dr Matsushita has received research funding from Fukuda Denshi; and has received personal fees from Fukuda Denshi and Kyowa Kirin outside of this work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the staff and participants of the ARIC study for their important contributions.

PY - 2021/11/16

Y1 - 2021/11/16

UR - https://www.scopus.com/pages/publications/85119953081

UR - https://www.scopus.com/pages/publications/85119953081#tab=citedBy

U2 - 10.1016/j.jacc.2021.08.066

DO - 10.1016/j.jacc.2021.08.066

M3 - Letter

C2 - 34763781

AN - SCOPUS:85119953081

SN - 0735-1097

VL - 78

SP - 2019

EP - 2021

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 20

ER -

The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this